Brad Reisfeld, a professor in the Department of Chemical and Biological Engineering, has been selected as a Fellow of the Academy of Toxicology Sciences – one of the highest honors awarded by his peers for an exemplary record of professional accomplishment.

Since joining CSU in 2010, Reisfeld has been actively involved in research and teaching involving computational and systems toxicology and pharmacology. He is also a member of the faculty in the School of Biomedical Engineering and the Colorado School of Public Health.

Reisfeld’s research has advanced the modeling of biological systems leading to a better understanding of the disposition and effects of drug and environmental toxicants on humans and animals.

In 2016, he was awarded a U.S. Food and Drug Administration grant to develop a model to better evaluate generic drug candidates, while considering differences in a subject’s physiology and genetics.

Reisfeld’s model for optimizing dosing to more effectively treat pulmonary tuberculosis, a disease that kills 1 million people every year in developing nations, was published by the American Society for Microbiology. And a U.S. Scholar Grant from the Fulbright Foundation led him to Thailand in 2016 where he developed models for investigating chemical pathways associated with diseases like malaria, HIV, and Steven-Johnson Syndrome.

In addition to his Fellow status, Reisfeld is currently President of the Biological Modeling Specialty Section of the Society of Toxicology and is a Diplomate of the American Board of Toxicology.